Does CARBOPLATIN\PACLITAXEL Cause Product use in unapproved indication? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product use in unapproved indication have been filed in association with CARBOPLATIN\PACLITAXEL. This represents 6.8% of all adverse event reports for CARBOPLATIN\PACLITAXEL.
5
Reports of Product use in unapproved indication with CARBOPLATIN\PACLITAXEL
6.8%
of all CARBOPLATIN\PACLITAXEL reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product use in unapproved indication From CARBOPLATIN\PACLITAXEL?
Of the 5 reports, 3 (60.0%) required hospitalization.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARBOPLATIN\PACLITAXEL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CARBOPLATIN\PACLITAXEL Cause?
Neuropathy peripheral (6)
Drug ineffective (5)
Fatigue (5)
Malignant neoplasm progression (5)
Nausea (5)
Off label use (5)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)